Antiviral Trio Shows Mettle Against COVID-19

FRIDAY, May 8, 2020 — A triple whammy of three antiviral drugs shows promise in fighting mild to moderate COVID-19, a new, small study suggests.
Two weeks of interferon beta-1b, lopinavir-ritonavir and ribavirin — along with standard care — was…
Source: Topamax